title: Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells.
abstract: Hepatic oxidative stress and lipid peroxidation are common features of several prevalent disease states, including alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD), a common component of the metabolic syndrome. These conditions are characterized in part by excessive accumulation of lipids within hepatocytes, which can lead to autocatalytic degradation of cellular lipids giving rise to electrophilic end products of lipid peroxidation. The pathobiology of reactive lipid aldehydes remains poorly understood. We therefore sought to investigate the effects of 4-hydroxynonenal (4-HNE) and 4-oxononenal (4-ONE) on the transport and secretion of very low-density lipoprotein using HepG2 cells as a model hepatocyte system. Physiologically relevant concentrations of 4-HNE and 4-ONE rapidly disrupted cellular microtubules in a concentration-dependent manner. Interestingly, 4-ONE reduced apolipoprotein B-100 (ApoB) secretion while 4-HNE did not significantly impair secretion. Both 4-HNE and 4-ONE formed adducts with ApoB protein, but 4-HNE adducts were detectable as mono-adducts, while 4-ONE adducts were present as protein-protein cross-links. These results demonstrate that reactive aldehydes generated by lipid peroxidation can differ in their biological effects, and that these differences can be mechanistically explained by the structures of the protein adducts formed.
authors.affiliation: Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, 80045, USA. Benjamin.Stewart@ucdenver.edu
authors.forename: Benjamin J
authors.initials: BJ
authors.lastname: Stewart
authors.forename: James R
authors.initials: JR
authors.lastname: Roede
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Doorn
authors.forename: Dennis R
authors.initials: DR
authors.lastname: Petersen
mesh_terms: D000447:Aldehydes / Q000494:pharmacology*; D053299:Apolipoprotein B-100 / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D003432:Cross-Linking Reagents / Q000494:pharmacology*; D006801:Humans; D042541:Intracellular Space / Q000187:drug effects / Q000378:metabolism; D008055:Lipids / Q000494:pharmacology; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors; D014404:Tubulin / Q000378:metabolism
chemical_list: D000447:Aldehydes; D053299:Apolipoprotein B-100; D002352:Carrier Proteins; D003432:Cross-Linking Reagents; D008055:Lipids; D014404:Tubulin; C106092:microsomal triglyceride transfer protein; C027576:4-hydroxy-2-nonenal